Lipoedema: Health Services

(asked on 22nd January 2026) - View Source

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, whether he has considered adopting approaches to lipoedema treatment used by other European countries, like Germany and Spain.


Answered by
Ashley Dalton Portrait
Ashley Dalton
Parliamentary Under-Secretary (Department of Health and Social Care)
This question was answered on 27th January 2026

Women with lipoedema can face a number of barriers to seeking diagnosis and referral, including long waits, misdiagnosis, often as obesity or lymphoedema, and low awareness of the condition among both the public and some healthcare professionals. These factors can lead to delayed recognition, worsening symptoms, and reduced confidence in seeking care.

We recognise the need to improve awareness and understanding of lipoedema. To support earlier, more accurate diagnosis, the Royal College of General Practitioners (RCGP) has worked in partnership with Lipoedema UK to develop a dedicated e‑learning module for general practitioners, covering the presentation, pathophysiology, diagnosis, and management of lipoedema in primary care. This resource is freely available to RCGP members.

Access to specialist assessment and treatment for lipoedema is commissioned locally by integrated care boards, which are best placed to understand local population need. Treatment options may include compression therapy, simple lymphatic drainage, self‑management support and, in severe cases, consideration of liposuction in line with interventional procedures guidance published by the National Institute for Health and Care Excellence (NICE). Clinicians may offer treatment where appropriate, using their professional judgment and taking advice published by NICE into account.

We are aware that some European countries, including Germany, have expanded access to liposuction for lipoedema following emerging evidence from the German LiPLEG study into liposuction. In England, NICE’s current guidance advises that evidence on the safety and efficacy of liposuction for chronic lipoedema remains limited, and it should only be offered with appropriate clinical governance and safeguards. NICE will review this guidance once the full LiPLEG data is available.

Reticulating Splines